Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Affymetrix Inc.

Sep 2006
Affymetrix Inc. of Santa Clara, Calif., has given nonexclusive access to Epigenomics AG of Berlin for its microarray technology. With this agreement, the German company will be able to develop and market microarray-based in vitro diagnostic tests for cancer and other diseases using Affymetrix’s DNA methylation methods.

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2017 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!